Results 11 to 20 of about 86,733,728 (163)

Patient Selection for Mitral Transcatheter Edge-to-Edge Repair

Methodist DeBakey Cardiovascular Journal, 2023
Mitral regurgitation (MR) is one of the most common valvular heart diseases, with many patients remaining non-suitable for surgical interventions. Transcatheter edge-to-edge repair (TEER) is a rapidly evolving procedure that allows safe and effective ...
Habib Layoun, Serge C. Harb, Amar Krishnaswamy, Rhonda Miyasaka, James Yun, Samir R. Kapadia   +5 more
doaj   +2 more sources

Recent Evidence and Initial Experiences of Transcatheter Edge-to-Edge Repair of the Mitral Valve in South Korea [PDF]

Journal of Chest Surgery, 2021
As a percutaneous technique for the reduction of mitral regurgitation, the MitraClip system (Abbott Vascular, Abbott Park, IL, USA) for transcatheter edge-to-edge repair of the mitral valve was developed in 1998 and first used in 2003. Its main advantage
Sung-Jin Hong, Jung-Sun Kim, Geu-Ru Hong
doaj   +2 more sources

Association of Systemic Inflammatory Response Syndrome With Cardiovascular Events After Mitral Transcatheter Edge‐to‐Edge Repair [PDF]

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Systemic inflammatory response syndrome (SIRS) following cardiovascular interventions is associated with adverse events during hospitalization and follow‐up.
Carlo Mannina, Akarsh Sharma, Andreina Carbone, Eduardo Bossone, Antonino Tuttolomondo, Edgar Argulian, Eric Neibart, Michael B. Hadley, Jonathan Halperin, George Dangas, Samin K. Sharma, Annapoorna Kini, Stamatios Lerakis   +12 more
doaj   +2 more sources

Advanced Steering Maneuvers for Special Situations in Mitral Valve Transcatheter Edge-to-edge Repair [PDF]

US Cardiology Review, 2022
The use of transcatheter percutaneous edge-to-edge mitral valve repair with the MitraClip (Abbott) for the treatment of mitral regurgitation has rapidly expanded since it received Food and Drug Administration approval.
Vikram Sharma, Arpit Sothwal, Jai Parekh, Sidakpal Panaich   +3 more
doaj   +2 more sources

Mitral Transcatheter Edge-to-Edge Repair With the PASCAL Precision System: Device Knobology and Review of Advanced Steering Maneuvers [PDF]

Structural Heart
In 2022, the Food and Drug Administration approved a second mitral transcatheter edge-to-edge repair device for the treatment of primary mitral regurgitation (PASCAL Precision Transcatheter Valve Repair System, Edwards Lifesciences, Irvine, CA).
Santiago Garcia, MD, Sammy Elmariah, MD, Robert J. Cubeddu, MD, Firas Zahr, MD, Mackram F. Eleid, MD, Susheel K. Kodali, MD, Puvi Seshiah, MD, Rahul Sharma, MD, D. Scott Lim, MD   +8 more
doaj   +2 more sources

Impact of Atrial Fibrillation in Patients With Severe Mitral Regurgitation Undergoing Transcatheter Edge‐to‐Edge Repair

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Atrial fibrillation (AF) and mitral regurgitation (MR) are closely linked, and one may worsen the other. We investigated the impact of baseline AF in patients with MR undergoing transcatheter edge‐to‐edge repair.
Carlo Mannina, Akarsh Sharma, Yash Prakash, Andreina Carbone, Eduardo Bossone, Antonino Tuttolomondo, Edgar Argulian, Sahil Khera, Parasuram Melarcode‐Krishnamoorthy, George Dangas, Jonathan Halperin, Gilbert H. L. Tang, Samin Sharma, Annapoorna Kini, Gregg W. Stone, Stamatios Lerakis   +15 more
doaj   +2 more sources

Transcatheter Edge-to-Edge Mitral Valve Repair in a Patient With Anderson-Fabry Disease

JACC: Case Reports
Severe degenerative mitral regurgitation (DMR) is one cardiac manifestation of the multiorgan metabolic enzyme disorder Anderson-Fabry Disease (AFD). Although DMR is normally managed surgically, many patients with AFD are unsuitable for this.
Mohamed Elwashahy, MD, Jason Sharp, MBBS, Dennis Wang, MBBS, Tuan Nguyen-Dang, MD, Jorge Moragues, MD, Edward J.F. Danson, BMBCh, MA(Oxon), DPhil(Lond)   +5 more
doaj   +2 more sources

Mitral valve transcatheter edge-to-edge repair. [PDF]

, 2023
Mitral regurgitation (MR) is the most prevalent valvular heart disease and, when left untreated, results in reduced quality of life, heart failure, and increased mortality.
Karam, Nicole, Stocker, Thomas J, Adamo, Marianna, Praz, Fabien, Hausleiter, Jörg, Swaans, Martin J   +5 more
core   +1 more source

Hemolytic Anemia After Surgical Mitral Valve Repair Treated With Transcatheter Edge-to-Edge Device [PDF]

, 2022
An 80-year-old woman with mitral valve repair failure was admitted with hemolytic anemia secondary to the impact of a regurgitant jet on the annuloplasty ring.
Ligero, Carmen, Viladés, David, Tauron, Manel, Millan, Xavier, Li, Chi-Hion Pedro, Arzamendi, Dabit, Ruiz-López, Adrià, Valdovinos, Pilar, Viladés Medel, David, Bonet, Ana, Alegret, Josep M., Rodríguez, Álvaro, Alegret i Colomé, Josep Maria, Universitat Autònoma de Barcelona   +13 more
core   +1 more source

Concomitant Transcatheter Edge-to-Edge Treatment of Secondary Tricuspid and Mitral Regurgitation: An Expert Opinion [PDF]

, 2023
: Secondary (functional) tricuspid regurgitation (sTR) is common in patients with mitral regurgitation (MR). Because combined valvular heart disease affects long-term survival, in comparison with isolated MR or tricuspid regurgitation, it is essential to
Maisano, Francesco, Latib, Azeem, Praz, Fabien, Hahn, Rebecca T, Sorajja, Paul, Messika-Zeitoun, David, Godino, Cosmo, Agricola, Eustachio, Fam, Neil, Caravita, Sergio, Margonato, Alberto, Sisinni, Antonio, Adamo, Marianna, Estevez-Loureiro, Rodrigo, von Bardeleben, Ralph Stephan, Taramasso, Maurizio, Metra, Marco, Conradi, Lenard   +17 more
core   +1 more source